Comparing two treatments to reduce cervical cancer risk in women with HIV
Part of Immune system & allergy, Infections clinical trials.
This study compares two treatments (Thermal Ablation and LEEP) to lower the risk of cervical cancer in women living with HIV. It aims to find which option works better and is safer for this group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between the ages of 25 and 49.
- You have tested positive for HIV.
- You are willing and able to take part in the study and give your consent.
- You are not currently pregnant and it has been at least 6 weeks since giving birth.
- You still have your cervix (you have not had a hysterectomy).
- You have never had cervical cancer or received treatment for abnormal cervical cells.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a chemotherapy cream (5-fluorouracil) applied after heat treatment can better prevent cervical and anal precancers in women with HIV. The goal is to improve outcomes for women in Kenya who test positive for HPV, a virus that can cause cancer.
This trial tests whether adding HPV vaccination to the cervical cancer screening plan—while you get care at HIV (ARV) clinics—improves prevention of cervical problems. It focuses on women with HIV aged 25–35 to help reduce HPV-related cervical disease over time.
This trial tests a program to screen and treat HIV-positive women for cervical cancer in La Romana, Dominican Republic. It may help catch and manage cervical cancer early.
This trial compares two ways to help women with HIV get screened for cervical cancer: a clinic-based approach versus a combined clinic and community outreach program. You may be able to provide samples yourself at a clinic or at home to test for HPV, the virus that can cause cervical cancer.
This study follows women with an early abnormal cervix cell change (CIN2/CIN2-3) to see how HPV DNA “integration” relates to whether the condition improves or worsens. It may help doctors better predict prognosis and guide safer monitoring, especially if you want to become pregnant.
This study tests two different approaches to treating early cervical changes in women living with HIV who tested positive for HPV (a virus that can cause cervical cancer). The goal is to see which approach works better and is easier to use in South Africa.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.